Prof. Thomas Stieglitz on Brain-Computer-Interfaces (BCI)

Interfaces to the brain have already found their way into applications in clinical practice. Results of research and human studies are widely shared on social media. The names used, such as "Computer-Brain-Interfaces", were originally closely linked to the location and performance of the approaches.

The authors Ulrich G. Hoffmann and Thomas Stieglitz argue for precise terminology when discussing neurotechnologies, in particular for a distinction between "Brain-Computer-Interfaces" (BCIs) and "Brain-Machine-Interfaces" (BMIs). They point out the surgical risks and invasiveness associated with these technologies and emphasize that implantable systems (BMIs) differ significantly from non-invasive BCIs in terms of risks, performance and potential side effects. They advocate the use of different terms to better inform the public and provide safety and clarity in this area and suggest "iBCI" for invasive devices. This clarity is intended to increase public confidence and informed decision-making regarding neurotechnological advances.

Link to the article: https://rdcu.be/dOH0x

Contact:

Thomas Stieglitz
Director
Department of Microsystems Engineering – IMTEK
Biomedical Microtechnology
IMBIT - NeuroProbes
University of Freiburg
Tel.: +49 761 203-7471
E-Mail: stieglitz@imtek.uni-freiburg.de

Kerstin Steiger-Merx
Representative PR/Marketing
Faculty of Enginering
University of Freiburg
Tel.: 0761/203-8056
E-Mail: steiger-merx@tf.uni-freiburg.de